Cardoz AB, founded in 2006, is a Stockholm-based pharmaceutical company exploring new medical approaches to treat vascular diseases such as abdominal aortic aneurysm and atherosclerosis.

Cardoz is developing drugs with unique properties to reduce vascular inflammation.